Improvement of a capillary electrophoresis/frontal analysis (CE/FA) method for determining binding constants: Discussion on relevant parameters

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 5, 2010, Pages 1288-1297

  Vuignier, Karine ^a   Schappler, Julie ^a   Veuthey, Jean Luc ^a   Carrupt, Pierre Alain ^a   Martel, Sophie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Binding constants; Capillary electrophoresis; Frontal analysis; Plasma proteins

Indexed keywords

BOVINE SERUM ALBUMIN; BUPIVACAINE; CARBAMAZEPINE; DICLOFENAC; LIDOCAINE; PHENOBARBITAL; PLASMA PROTEIN; PROPRANOLOL; SALICYLIC ACID; TRYPTOPHAN; WARFARIN;

ADSORPTION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CAPILLARY ELECTROPHORESIS; CAPILLARY WALL; CONTROLLED STUDY; DRUG PROTEIN BINDING; ELECTRIC FIELD; ELECTRIC POTENTIAL; ELECTROPHORETIC MOBILITY; EQUILIBRIUM CONSTANT; MOLECULAR INTERACTION; PH; PRIORITY JOURNAL;

ANIMALS; BLOOD PROTEINS; CATTLE; CHEMISTRY, PHARMACEUTICAL; ELECTROPHORESIS, CAPILLARY; PHARMACEUTICAL PREPARATIONS; PROTEIN BINDING; SERUM ALBUMIN, BOVINE; WARFARIN;

EID: 77955927995     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.024     Document Type: Article

References (65)

1. Trainor G.L. The importance of plasma protein binding in drug discovery. Expert Opin. Drug Discov. 2007, 2:51-64.
2. Lindup W.E., L'E.Orme M.C. Plasma protein binding of drugs. Br. Med. J. 1981, 282:212-214.
3. Lohman J.J.H.M. Plasma protein binding of drugs. Pharm. Weekblad Sci. Ed. 1986, 8:302-304.
4. Kratochwil N.A., Huber W., Muller F., Kansy M., Gerber P.R. Predicting plasma protein binding of drugs: a new approach. Biochem. Pharmacol. 2002, 64:1355-1374.
5. Wan H., Holmen A.G. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery. Comb. Chem. High Throughput Screen 2009, 12:315-329.
6. Berezhkovskiy L.M. Some features of the kinetics and equilibrium of drug binding to plasma proteins. Expert Opin. Drug Metab. Toxicol. 2008, 4:1479-1498.
7. K. Vuignier, J. Schappler, J.L. Veuthey, P.A. Carrupt, S. Martel, Drug-protein binding: a critical review of analytical tools, Anal. Bioanal. Chem. (2010), in press.
8. Howard M.I., Hill J.J., Galluppi G.R., Mclean M.A. Plasma protein binding in drug discovery and development. Comb. Chem. High Throughput Screen 2010, 13:1-18.
9. Connors K.A. Binding Constants-The Measurement of Molecular Complex Stability 1987, J. Wiley.
10. Huang J. Errors in estimating the unbound fraction of drugs due to the volume shifts in equilibrium dialysis. J. Pharm. Sci. 1983, 72:1368-1369.
11. Lockwood G.F., Wagner J.G. Plasma-volume changes as a result of equilibrium dialysis. J. Pharm. Pharmacol. 1983, 35:387-388.
12. Oravcova J., Bohs B., Lindner W. Drug-protein binding studies: new trends in analytical and experimental methodology. J. Chromatogr. B 1996, 677:1-28.
13. Mapleson W.W. Computation of the effect of Donnan equilibrium on Ph in equilibrium dialysis. J. Pharmacol. Meth. 1987, 17:231-242.
14. Zini R. Methods in drug protein binding analysis. Human Pharmacology. The Basis of Clinical Pharmacology 1991, 235-282. Elsevier Science Publishers, Amsterdam. H. Kuemmerle, T. Shibuya, J.P. Tillement (Eds.).
15. Liu Y.C., Yang Z.Y., Du J., Yao X.J., Lei R.X., Zheng X.D., Liu J.N., Hu H.S., Li H. Study on the interactions of kaempferol and quercetin with intravenous immunoglobulin by fluorescence quenching, Fourier transformation infrared spectroscopy and circular dichroism spectroscopy. Chem. Pharm. Bull. 2008, 56:443-451.
16. Mathur S., Badertscher M., Scott M., Zenobi R. Critical evaluation of mass spectrometric measurement of dissociation constants: accuracy and cross-validation against surface plasmon resonance and circular dichroism for the calmodulin-melittin system. Phys. Chem. Chem. Phys. 2007, 9:6187-6198.
17. Velazquez-Campoy A., Ohtaka H., Nezami A., Muzammil S., Freire E. Isothermal titration calorimetry. Curr. Protocols Cell Biol. 2004, 17:1-24.
18. Velazquez-Campoy A., Leavitt S.A., Freire E. Characterization of protein-protein interactions by isothermal titration calorimetry. Protein-Protein Interactions 2004, pp. 35-54.
19. Haines P.J. Principles of thermal analysis calorimetry 2002, Royal Society of Chemistry, Cambridge.
20. Perozzo R., Folkers G., Scapozza L. Thermodynamics of protein-ligand interactions: history, presence, and future aspects. J. Recept. Signal Transduct. 2004, 24:1-52.
21. Ascoli G.A., Domenici E., Bertucci C. Drug binding to human serum albumin: Abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006, 18:667-679.
22. Hage D.S., Jackson A., Sobansky M.R., Schiel J.E., Yoo M.J., Joseph K.S. Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J. Sep. Sci. 2009, 32:835-853.
23. R.B.M. Schasfoort, A.J. Tudos, Handbook of Surface Plasmon Resonance, Eds. R. B. M. Schasfoort and A. J. Tudos, The Royal Society of Chemistry, Cambridge, 2008.
24. Rich R.L., Myszka D.G. Advances in surface plasmon resonance biosensor analysis. Curr. Opin. Biotechnol. 2000, 11:54-61.
25. Day Y.S.N., Baird C.L., Rich R.L., Myszka D.G. Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods. Protein Sci. 2002, 11:1017-1025.
26. Pattnaik P. Surface plasmon resonance: applications in understanding receptor-ligand interaction. App. Biochem. Biotechnol. 2005, 126:79-92.
27. Heegaard N.H.H., Nilsson S., Guzman N.A. Affinity capillary electrophoresis: important application areas and some recent developments. J. Chromatogr. B 1998, 715:29-54.
28. Heegaard N.H.H., Kennedy R.T. Identification, quantitation, and characterization of biomolecules by capillary electrophoretic analysis of binding interactions. Electrophoresis 1999, 20:3122-3133.
29. Jiang C., Armstrong D.W. Use of CE for the determination of binding constants. Electrophoresis 2010, 31:17-27.
30. Busch M.H.A., Carels L.B., Boelens H.F.M., Kraak J.C., Poppe H. Comparison of five methods for the study of drug-protein binding in affinity capillary electrophoresis. J. Chromatogr. A 1997, 777:311-328.
31. Busch M.H.A., Kraak J.C., Poppe H. Principles and limitations of methods available for the determination of binding constants with affinity capillary electrophoresis. J. Chromatogr. A 1997, 777:329-353.
32. Martinez-Pla J.J., Martinez-Gomez M.A., Martin-Biosca Y., Sagrado S., Villanueva-Camanas R.M., Medina-Hernandez M.J. High-throughput capillary electrophoresis frontal analysis method for the study of drug interactions with human serum albumin at near-physiological conditions. Electrophoresis 2004, 25:3176-3185.
33. Zhao P., Zhu G., Zhang W., Zhang L., Liang Z., Zhang Y. Study of multiple binding constants of dexamethasone with human serum albumin by capillary electrophoresisΓÇôfrontal analysis and multivariate regression. Anal. Bioanal. Chem. 2009, 393:257-261.
34. Lu Q.H., Ba C.D., Chen D.Y. Investigating noncovalent interactions of rutin-serum albumin by capillary electrophoresis: frontal analysis. J. Pharm. Biomed. Anal. 2008, 47:888-891.
35. Ishihama Y., Miwa T., Asakawa N. Drug--plasma protein binding assay by electrokinetic chromatography-frontal analysis. Electrophoresis 2002, 23:951-955.
36. McDonnell P.A., Caldwell G.W., Masucci J.A. Using capillary electrophoresis frontal analysis to screen drugs interacting with human serum proteins. Electrophoresis 1998, 19:448-454.
37. Ding Y.S., Zhu X.F., Lin B.C. Capillary electrophoresis study of human serum albumin binding to basic drugs. Chromatographia 1999, 49:343-346.
38. Jia Z.J., Ramstad T., Zhong M. Determination of protein-drug binding constants by pressure-assisted capillary electrophoresis (PACE)/frontal analysis (FA). J. Pharm. Biomed. Anal. 2002, 30. II.
39. De Lorenzi E., Galbusera C., Bellotti V., Mangione P., Massolini G., Tabolotti E., Andreola A., Caccialanza G. Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis. Electrophoresis 2000, 21:3280-3289.
40. Ostergaard J., Schou C., Larsen C., Heegaard N.H.H. Evalution of capillary electrophoresis-frontal analysis for the study of low molecular weight drug-human serum albumin interactions. Electrophoresis 2002, 23:2842-2853.
41. Wan H., Ostlund A., Jonsson S., Lindberg W. Single run measurements of drug-protein binding by high-performance frontal analysis capillary electrophoresis and mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19(12):1603-1610.
42. Ohnishi T., Mohamed N.A.L., Shibukawa A., Kuroda Y., Nakagawa T., El Gizawy S., Askal H.F., El Kommos M.E. Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis. J. Pharm. Biomed. Anal. 2002, 27:607-614.
43. Zhou D., Li F. Protein binding study of clozapine by capillary electrophoresis in the frontal analysis mode. J. Pharm. Biomed. Anal. 2004, 35:879-885.
44. Mohamed N.A.L., Kuroda Y., Shibukawa A., Nakagawa T., El Gizawy S., Askal H.F., El Kommos M.E. Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis. J. Chromatogr. A 2000, 875:447-453.
45. Busch M.H.A., Boelens H.F.M., Kraak J.C., Poppe H., Meekel A.A.P., Resmini M. Critical evaluation of the applicability of capillary zone electrophoresis for the study of hapten-antibody complex formation. J. Chromatogr. A 1996, 744:195-203.
46. Ostergaard J., Schou C., Larsen C., Heegaard N.H.H. Effect of dextran as a run buffer additive in drug-protein binding studies using capillary electrophoresis frontal analysis. Anal. Chem. 2003, 75:207-214.
47. Pedersen J.T., Ostergaard J., Houen G., Heegaard N.H.H. Affinity capillary electrophoresis for identification and investigation of human Gc-globulin (vitamin D-binding protein) and its isoforms interacting with G-actin. Electrophoresis 2008, 29:1723-1733.
48. Zhao X., You T., Liu J., Sun X., Yan J., Yang X., Wang E. Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection. Electrophoresis 2004, 25:3422-3426.
49. Jia Z. Physicochemical profiling by capillary electrophoresis. Curr. Pharm. Anal. 2005, 1:41-56.
50. Rundlett K.L., Armstrong D.W. Methods for the determination of binding constants by capillary electrophoresis. Electrophoresis 2001, 22:1419-1427.
51. Ostergaard J., Heegaard N.H.H. Bioanalytical interaction studies executed by preincubation affinity capillary electrophoresis. Electrophoresis 2006, 27:2590-2608.
52. Honore B., Brodersen R. Albumin binding of anti-inflammatory drugs-utility of a site-oriented versus a stoichiometric analysis. Mol. Pharmacol. 1984, 25:137-150.
53. Lucy C.A., MacDonald A.M., Gulcev M.D. Non-covalent capillary coatings for protein separations in capillary electrophoresis. J. Chromatogr. A 2008, 1184:81-105.
54. Kwon Y. Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists 2001, Springer Verlag, New York.
55. Hage D.S. Chromatographic and electrophoretic studies of protein binding to chiral solutes. J. Chromatogr. A 2001, 906:459-481.
56. Winzor D.J. Determination of binding constants by analogous procedures in size exclusion chromatography and capillary electrophoresis. Anal. Biochem. 2008, 383:1-17.
57. Kochansky C.J., McMasters D.R., Lu P., Koeplinger K.A., Kerr H.H., Shou M., Korzekwa K.R. Impact of pH on plasma protein binding in equilibrium dialysis. Mol. Pharm. 2008, 5:438-448.
58. Shimura K., Kasai K. Affinity capillary electrophoresis: A sensitive tool for the study of molecular interactions and its use in microscale analyses. Anal. Biochem. 1997, 251:1-16.
59. Winzor D.J. A need for caution in the use of frontal analysis continuous capillary electrophoresis for the determination of ligand binding data. Anal. Biochem. 2006, 349:285-291.
60. Fielding L., Rutherford S., Fletcher D. Determination of protein-ligand binding affinity by NMR: observations from serum albumin model systems. Magn. Reson. Chem. 2005, 43:463-470.
61. Bailey D.N., Briggs J.R. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro. Ther. Drug Monit. 2004, 26:40-43.
62. Terasaki T., Pardridge W.M., Denson D.D. Differential effect of plasma-protein binding of bupivacaine on its invivo transfer into the brain and salivary-gland of rats. J. Pharmacol. Exp. Ther. 1986, 239:724-729.
63. Dutta S.K., Basu S.K., Sen K.K. Binding of diclofenac sodium with bovine serum albumin at different temperatures, pH and ionic strengths. Indian J. Exp. Biol. 2006, 44:123-127.
64. Hosseinzadeh R., Maleki R., Matin A.A. Interaction of diclofenac with bovine serum albumin investigated by diclofenac-selective electrode. Acta Chim. Slov. 2007, 54:126-130.
65. Ozeki S., Tejima K. Drug interactions .3. Binding to and displacement from bovine serum-albumin of barbiturates. Chem. Pharm. Bull. 1977, 25:1952-1958.